Clinical and biochemical assessment of hypogonadism in men with type 2 diabetes: Correlations with bioavailable testosterone and visceral adiposity

Diabetes Care

Volumn 30, Issue 4, 2007, Pages 911-917

  Kapoor, Dheeraj ^a,b   Aldred, Hazel ^a   Clark, Stephanie ^b   Channer, Kevin S ^c   Jones, T Hugh ^a,b  

^a BARNSLEY HOSPITAL NHS FOUNDATION TRUST   (United Kingdom)

^b UNIVERSITY OF SHEFFIELD   (United Kingdom)

^c ROYAL HALLAMSHIRE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

HEMOGLOBIN A1C; INSULIN; ORAL ANTIDIABETIC AGENT; SEX HORMONE BINDING GLOBULIN; TESTOSTERONE;

ADULT; AGED; ARTICLE; BIOAVAILABILITY; BLOOD PRESSURE; BODY MASS; CHEMICAL ANALYSIS; CLINICAL ASSESSMENT; CLINICAL FEATURE; CONTROLLED STUDY; DIET THERAPY; DISEASE ASSOCIATION; HUMAN; HYPOGONADISM; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PREVALENCE; SMOKING; TESTOSTERONE BLOOD LEVEL; WAIST CIRCUMFERENCE;

ADIPOSE TISSUE; ADULT; AGED; AGED, 80 AND OVER; BIOLOGICAL AVAILABILITY; BODY MASS INDEX; BODY SIZE; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS, TYPE 2; HUMANS; HYPOGONADISM; IMPOTENCE; MALE; MIDDLE AGED; OBESITY; SEX HORMONE-BINDING GLOBULIN; TESTOSTERONE; VISCERA;

EID: 34147104552     PISSN: 01495992     EISSN: 01495992     Source Type: Journal    
DOI: 10.2337/dc06-1426     Document Type: Article

References (44)

1. Kapoor D, Malkin CJ, Channer KS, Jones TH: Androgens, insulin resistance and vascular disease in men. Clin Endocrinol (Oxf) 63:239-250, 2005
2. Simon D, Preziosi P, Barrett-Connor E, Roger M, Saint-Paul M, Nahoul K, Papoz L: Interrelation between plasma testosterone and plasma insulin in healthy adult men: the Telecom Study. Diabetologia 35:173-177, 1992
3. Oh JY, Barrett-Connor E, Wedick NM, Wingard DL: Endogenous sex hormones and the development of type 2 diabetes in older men and women. Diabetes Care 25:55-60, 2002
4. Stellato RK, Feldman HA, Hamdy O, Horton ES, McKinlay JB: Testosterone, sex hormone binding globulin and the development of type 2 diabetes in middle aged men. Diabetes Care 23:490-494, 2000
5. Haffner SM, Shaten J, Stern MP, Smith GD, Kuller L: Low levels of sex hormone binding globulin and testosterone predict the development of non insulin dependent diabetes mellitus in men. Am J Epidemiol 143:889-897, 1996
6. Barrett-Connor E, Khaw KT, Yen SS: Endogenous sex hormone levels in older men with diabetes mellitus. Am J Epidemiol 132:895-901, 1990
7. Barrett-Connor E: Lower endogenous androgen levels and dyslipidemia in men with non insulin-dependent diabetes mellitus. Ann Intern Med 117:807-811, 1992
8. Andersson B, Marin P, Lissner L, Vermeulen A, Bjorntorp P: Testosterone concentrations in women and men with NIDDM. Diabetes Care 17:405-411, 1994
9. Dhindsa S, Prabhakar S, Sethi M, Bandyopadhyay A, Chaudhuri A, Dandona P: Frequent occurrence of hypogonadotropic hypogonadism in type 2 diabetes. J Clin Endocrinol Metab 89:5462-5468, 2004
10. Nieschlag E, Behre HM, Bouchard P, Corrales JJ, Jones TH, Stalla GK, Webb SM, Wu FCW: Testosterone replacement therapy: current trends and future directions. Hum Reprod Update 5:409-411, 2004
11. Leifke E, Gorenoi V, Wichers C, Muhlen A, Buren E, Brabant G: Age-related changes of serum sex hormones, insulin-like growth factor-1 and sex-hormone binding globulin levels in men: cross-sectional data from a healthy male cohort. Clin Endocrinol (Oxf) 53:689-695, 2000
12. Bhasin S, Cunningham GR, Hayes FJ, Matsumoto AM, Snyder PJ, Swerdloff RS, Montori VM: Testosterone therapy in adult men with androgen deficiency syndromes: An Endrocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab 91:1995-2010, 2006
13. Nieschlag E, Swerdloff R, Behre HM, Gooren LJ, Kaufman JM, Legros JJ, Lunenfeld B, Morley JE, Schulman C, Wang C, Weidner W, Wu FC: Investigation, treatment and monitoring of lateonset hypogonadism in males: ISA, ISSAM, and EAU recommendations. Int J Androl 28:125-127, 2005
14. Morley JE, Charlton E, Patrick P, Kaiser FE, Cadeau P, McCready D, Perry HM 3rd: Validation of a screening questionnaire for androgen deficiency in aging males. Metabolism 49:1239-1242, 2000
15. Fedele D, Coscelli C, Santeusanio F, Bortolotti A, Chatenoud L, Colli E, Landoni M, Parazzini F: Erectile dysfunction in diabetic subjects in Italy. Diabetes Care 21:1973-1977, 1998
16. McCulloch DK, Campbell IW, Wu FC, Prescott RJ, Clarke BF: The prevalence of diabetic impotence. Diabetologia 18:279-283, 1980
17. Kalinchenko SY, Kozlov GI, Gontcharov NP, Katsiya GV: Oral testosterone undecanoate reverses erectile dysfunction associated with diabetes mellitus in patients failing on sildenafil citrate therapy alone. Aging Male 6:94-99, 2003
18. Shabsigh R, Kaufman J, Steidle J, Padma-Nathan H: Randomized study of testosterone gel as adjunctive therapy to sildenafil in hypogonadal men with erectile dysfunction who do not respond to sildenafil alone. J Urol 172:658-663, 2004
19. Aversa A, Isidori AM, Spera G, Lenzi A, Fabbri A: Androgens improve cavernous vasodilation and response to sildenafil in patients with erectile dysfunction. Clin Endocrinol (Oxf) 58:632-638, 2003
20. Zumoff B, Strain GW, Miller LK, Rosner W, Senie R, Seres DS, Rosenfeld RS: Plasma free and non sex-hormone-binding-globulin-bound testosterone are decreased in obese men in proportion to their degree of obesity. J Clin Endocrinol Metab 71:929-931, 1990
21. Haffner SM, Valdez RA, Stern MP, Katz MS: Obesity, body fat distribution and sex hormones in men. Int J Obes 17:643-649, 1993
22. Simon D, Charles MA, Lahlou N, Nahoul K, Oppert JM, Gouault-Heilmann M, Lemort N, Thibult N, Joubert E, Balkau B, Eschwege E: Androgen therapy improves insulin sensitivity and decreases leptin level in healthy adult men with low plasma total testosterone. Diabetes Care 24:2149-2151, 2001
23. Marin P, Holmang S, Jonsson L, Sjostrom L, Kvist H, Holm G, Lindstedt G, Bjorntorp P: The effects of testosterone treatment on body composition and metabolism in middle-aged obese men. Int J Obes Relat Metab Disord 16:991-997, 1992
24. Marin P, Krotkiewski M, Bjorntorp P: Androgen treatment of middle-aged, obese men: effects on metabolism, muscle and adipose tissues. Eur J Med 1:329-336, 1992
25. Malkin CJ, Jones TH, Channer KS: The effect of testosterone on insulin sensitivity in men with heart failure. Eur J Heart Fail 9:40-50, 2007
26. Kapoor D, Goodwin E, Channer KS, Jones TH: Testosterone replacement therapy improves insulin resistance, glycaemic control, visceral adiposity and hypercholesterolaemia in hypogonadal men with type 2 diabetes. Eur J Endocrinol 154:899-906, 2006
27. Boyanov MA, Boneva Z, Christov VG: Testosterone supplementation in men with type 2 diabetes, visceral obesity and partial androgen deficiency. Aging Male 6:1-7, 2003
28. Corrales JJ, Burgo RM, Garca-Berrocal B, Almeida M, Alberca I, Gonzalez-Buitrago JM, Orfa A, Miralles JM: Partial androgen deficiency in aging type 2 diabetic men and its relationship to glycemic control. Metabolism 53:666-672, 2004
29. Tremblay RR, Dube JY: Plasma concentrations of free and non-TeBG bound testosterone in women on oral contraceptives. Contraception 10:599-605, 1974
30. Vermeulen A, Verdonck L, Kaufman JM: A critical evaluation of simple methods for the estimation of free testosterone in serum. J Clin Endocrinol Metab 84:3666-3672, 1999
31. Morales A, Lunenfeld B: Investigation, treatment and monitoring of late-onset hypogonadism in males: Official Recommendations of ISSAM. Aging Male 5:74-86, 2002
32. Harman SM, Metter EJ, Tobin JD, Pearson J, Blackman MR: Longitudinal effects of aging on serum total and free testosterone levels in healthy men. J Clin Endocrinol Metab 86:724-731, 2001
33. Muller M, Tonkelaar ID, Thijssen JHH, Grobbeee DE, Schouw YT: Endogenous sex hormones in men aged 40-80 years. Eur J Endocrinol 149:583-589, 2003
34. Ota K, Suehiro T, Ikeda Y, Arii K, Kumon Y, Hashimoto K: Diabetes mellitus associated with Klinefelter's syndrome: a case report and review in Japan. Intern Med 41:842-847, 2002
35. Cohen PG: The hypogonadal-obesity cycle. Med Hypotheses 52:49-51, 1999
36. Marin P, Oden B, Bjorntorp P: Assimilation and mobilization of triglycerides in subcutaneous abdominal and femoral adipose tissue in vivo in men: effects of androgens. J Clin Endocrinol Metab 80:239-243, 1995
37. Isidori AM, Caprio M, Strollo F, Moretti C, Frajese G, Isidori A, Fabbri A: Leptin and androgens in male obesity: evidence for leptin contribution to reduced androgens levels. J Clin Endocrinol Metab 84:3673-3680, 1999
38. Svartberg J, Jenssen T, Sundsfjord J, Jorde R: The associations of endogenous testosterone and sex hormone binding globulin with glycosylated hemoglobin levels, in community dwelling men: the Tromso Study. Diabete Metab 30:29-34, 2004
39. Iso H, Kiyama M, Naito Y, Sato S, Kitamura A, Iida M, Konishi M, Sankai T, Shimamoto T, Komachi Y: The relation of body fat distribution and body mass with haemoglobin A1c, blood pressure and blood lipids in urban Japanese men. Int J Epidemiol 20:88-94, 1991
40. Phillips GB, Jing TY, Resnick LM, Barbagallo M, Laragh JH, Sealey JE: Sex hormones and hemostatic risk factors for coronary heart disease in men with hypertension. J Hypertens 11:699-702, 1993
41. Kapoor D, Jones TH: Smoking and hormones in health and endocrine disorders. Eur J Endocrinol 152:491-499, 2005
42. English KM, Pugh P, Parry H, Scutt N, Channer KS, Jones TH: Effect of cigarette smoking on levels of bioavailable testosterone in healthy men. Clin Sci 100:661-665, 2001
43. English KM, Steeds RP, Jones TH, Diver MJ, Channer KS: Low dose transdermal testosterone therapy improves angina threshold in men with chronic stable angina. Circulation 102:1906-1911, 2000
44. Malkin CJ, Pugh PJ, West JN, van Beek EJR, Jones TH, Channer KS: Testosterone therapy in men with moderate severity heart failure: a randomised double blind placebo controlled trial. Eur Heart J 27:57-64, 2006